Personalized Medicine Shaping the Future of the Glioblastoma Market
The Glioblastoma Market is moving toward personalized medicine as researchers recognize that no two tumors behave exactly alike. Molecular profiling and genomic sequencing now allow clinicians to analyze tumor mutations and tailor treatment strategies accordingly. Instead of relying solely on broad chemotherapy regimens, doctors can select targeted drugs designed to interfere with specific...
0 Yorumlar 0 hisse senetleri 17 Views 0 önizleme
Lifesone https://lifesone.com